Skip to Main Content
Professional Photo

Tiffani V. Williams

Of Counsel

Tiffani Williams is senior vice president and public policy advisor with The Daschle Group, A Public Policy Advisory of Baker Donelson, and of counsel with Baker Donelson.

Professional Biography

Tiffani concentrates her practice on regulatory and legislative matters relating to the provision of health care services. Tiffani represents various segments of the health care industry, including hospitals, health care practitioners, community health centers, independent clinical laboratories, health plans, pharmaceutical and device manufacturers, dialysis providers, and related trade associations and industry coalitions.

Working to advance clients' public policy and business objectives in Washington, D.C., Tiffani has counseled clients on a variety of issues, including health care reform policy, congressional appropriations and funding, insurance coverage and reimbursement, HIPAA and fraud and abuse compliance, health information technology incentive programs and public health interventions. On these issues, she interfaces directly with Congress, as well as the administration and executive branch agencies within the Department of Health and Human Services. She assists clients with legislative and regulatory strategy and analysis, thought leadership, third-party outreach and engagement, responses to federal agency regulations and regularly prepares health care advisories, trending reports and position papers for clients.

In addition to advising clients on complex health care policy and regulatory matters, Tiffani also represents clients on policy and regulatory issues impacting the food, biofuel and agriculture industries.

  • Recognized as one of The Hill's "Top Lobbyists: Hired Guns" (2021)
  • Lawyers of Color's Top Lobbyists & Influencers (2019)
  • Washington D.C. Rising Star, Super Lawyers Magazine (2014)
  • Thelen, Reid & Priest Fellow – East Bay Community Law Center HIV/AIDS Law Center
  • Member – American Health Law Association (AHLA)
  • Board Member – Washington Government Relations Group (WGRG)
  • Member – Women Business Leaders of the U.S. Health Care Industry Foundation (WBL)
  • "Key Health Care Extenders Expiring During the 116th Congress," Washington, D.C. Update (September 2020)
  • "Congress's Surprise Billing Showdown" (February 2020)
  • "Consensus over Solutions to Surprise Medical Bills Continue to Remain Elusive" (September 2019)
  • "First Steps Toward ACA Marketplace Stabilization," Law360 (March 2017)
  • "First Lady and Nutrition: USDA and FDA Propose Sweeping Food Labeling and Marketing Regulations," DLA Piper Food Alert (February 2014)
  • "Affinity's Wipeout Shows Importance of Wiping Out PHI," Law360 (September 2013)
  • "Health Plan Pays for Failing to Erase Data on Leased Equipment: Two Takeaways for Companies Handling Electronic PHI," DLA Piper Health Care Alert (August 2013)
  • "WellPoint Agrees to Pay $1.7M in HIPAA Penalties: What This Tells You," DLA Piper Health Care Alert (July 2013)
  • "Long-Awaited Changes to the Health Insurance Portability and Accountability Act," DLA Piper Health Care Alert (February 2013)
  • "California's Proposition 37 and Food Policy: What Happens Next?," DLA Piper Food Alert (November 2012)
  • "The Long-Awaited Upgrade to Meaningful Use," DLA Piper Health Care Alert (March 2012)
  • "The Key Things to Know About ACOs," DLA Piper Health Care Alert (April 2011)
  • "Washington Policy Recap and A Look Ahead," American Association of Diabetes Educators, Advocacy webinar (December 2018)
  • "D.C. Health Care & Diabetes Update," American Association of Diabetes Educators, Public Policy Forum (June 2018)
  • "Political Policy Recap and Look Ahead," American Association of Diabetes Educators webinar (December 2017)


  • University of California at Berkeley, Boalt Hall School of Law, J.D., 2004
  • Yale University, School of Public Health and Epidemiology, M.P.H, 2001
  • American University, B.S., 1999


  • District of Columbia, 2005
  • New York, 2006

Featured Media

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept